Flag of the European Union EU Clinical Trials Register Help

Clinical trials for GI

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    725 result(s) found for: GI. Displaying page 1 of 37.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2007-001928-12 Sponsor Protocol Number: 17/2007/U/Sper Start Date*: 2007-04-23
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Contrast enhanced ultrasonography effectiveness in early evaluating of the response to the Sunitinib in the patients with advanced GIST. A pilot study
    Medical condition: Gastrointestinal stromal tumor (GIST)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061174 Gastrointestinal neoplasm LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-004624-41 Sponsor Protocol Number: 24092020 Start Date*: 2021-07-07
    Sponsor Name:Zealand University Hospital
    Full Title: Calcium Electroporation for Malignant GI Bleeding – a randomized controlled trial
    Medical condition: Malignant gastrointestinal bleeding
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10017936 Gastrointestinal bleeding LLT
    12.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10007129 Cancer-related morbidities HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-015070-35 Sponsor Protocol Number: RB 09.091 Start Date*: 2010-05-18
    Sponsor Name:CHRU de BREST
    Full Title: Evaluation de l'intérêt d'une préparation de l'intestin Grèle par polyéthylèneglycol pour l'exploration par vidéocapsule endoscopique des saignements digestifs inexpliqués
    Medical condition: Saignement digestif inexpliqué extériorisé ou non associé à une anémie
    Disease: Version SOC Term Classification Code Term Level
    12.1 10017871 Gastro intestinal bleeding LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017819-16 Sponsor Protocol Number: OP-GIB Start Date*: 2011-08-22
    Sponsor Name:Juan Cordoba
    Full Title: Efectos de la administración de ornitina-fenilacetato (OCR-002) en pacientes con cirrosis y hemorragia digestiva alta. Effects of the administration of ornithine phenylacetate (OP, OCR-002) in pati...
    Medical condition: Hemorragia digestiva en pacientes con cirrosis hepática
    Disease: Version SOC Term Classification Code Term Level
    13.1 10017947 - Gastrointestinal disorders 10019543 Hemorrhage gastrointestinal LLT
    13.1 10019805 - Hepatobiliary disorders 10019641 Hepatic cirrhosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-024309-11 Sponsor Protocol Number: ERITRO2011 Start Date*: 2011-03-16
    Sponsor Name:JOSEP MARIA BOTARGUES BOTÉ
    Full Title: Eritromicina versus lavados por sonda nasogástrica para mejorar la calidad visual de la endoscopia digestiva en pacientes con hemorragia digestiva alta. Ensayo clínico aleatorizado
    Medical condition: HEMORRAGIA DIGESTIVA ALTA
    Disease: Version SOC Term Classification Code Term Level
    13 10046284 Pérdida de sangre GI superior LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-000065-38 Sponsor Protocol Number: ASL607LIOM01 COMET-GI Start Date*: 2007-02-28
    Sponsor Name:AZIENDA USL 6 LIVORNO ZONA LIVORNESE
    Full Title: METRONOMIC CHEMOTHERAPY WITH URACIL/TEGAFUR (UFT), CYCLOPHOSPHAMIDE (CTX) AND CELECOXIB IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES: A PILOT CLINICAL STUDY WITH PHARMACOKINET...
    Medical condition: PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061174 Gastrointestinal neoplasm LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-003192-19 Sponsor Protocol Number: ISRCTN11225767 Start Date*: 2013-02-22
    Sponsor Name:London School Of Hygiene and Tropical Medicine
    Full Title: Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial
    Medical condition: Gastrointestinal hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10017960 Gastrointestinal hemorrhage LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) RO (Completed) ES (Prematurely Ended) IE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-006102-19 Sponsor Protocol Number: OM1 Start Date*: 2008-02-25
    Sponsor Name:Hospital General Universitario Gregorio Marañón de Madrid
    Full Title: Tratamiento con omeprazol para la profilaxis de la hemorragia digestiva y el reflujo gastroesofágico en niños críticos Omeprazol treatment for prophylaxis of gastrointestinal bleeding and gastroes...
    Medical condition: Profilaxis de hemorragia digestiva y prevención del reflujo gastroesofágico en niños críticos
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017936 Gastrointestinal bleeding LLT
    9.1 10017924 Gastroesophageal reflux LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-001077-13 Sponsor Protocol Number: CICL670A2417 Start Date*: 2011-08-11
    Sponsor Name:Novartis Farmacéutica S.A.
    Full Title: Estudio clínico multicéntrico, aleatorizado, comparativo, de distintos regímenes de administración de deferasirox en la tolerabilidad gastrointestinal (GI), en pacientes con síndrome mielodisplásic...
    Medical condition: Sobrecarga de hierro de riesgo bajo o intermedio (int-1) en pacientes con síndrome mielodisplásico (SMD) con ferritina > 1000 mcg/L en la selección o antecedentes de transfusión de por lo menos 20 ...
    Disease: Version SOC Term Classification Code Term Level
    14.0 10027433 - Metabolism and nutrition disorders 10022979 Iron excess HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-001197-18 Sponsor Protocol Number: NOR-BGT-14-10665 Start Date*: 2015-05-20
    Sponsor Name:Biogen Idec Norway
    Full Title: The effect of Tecfidera® (Dimethyl Fumarate) on the gut microbiota as a causal factor for GI associated adverse events.
    Medical condition: multiple sclerosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: View results
    EudraCT Number: 2015-000318-24 Sponsor Protocol Number: RH-ITA-006 Start Date*: 2016-08-30
    Sponsor Name:Dept. of Intensive Care 4131, Copenhagen University Hospital Rigshospitalet
    Full Title: Stress Ulcer Prophylaxis in the Intensive Care Unit
    Medical condition: Prophylaxis of stress related gastrointestinal bleeding among critically ill patients in the intensive care unit.
    Disease: Version SOC Term Classification Code Term Level
    19.1 10042613 - Surgical and medical procedures 10022519 Intensive care PT
    19.1 100000004856 10071910 Upper gastrointestinal bleeding LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) FI (Completed) NO (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2009-016716-20 Sponsor Protocol Number: 08/152/WRI Start Date*: 2010-03-03
    Sponsor Name:Brighton and Sussex University Hospitals NHS Trust
    Full Title: Better targeting of antidepressants in older people: the influence of age and genetic background on serotonin signalling
    Medical condition: Depression
    Disease: Version SOC Term Classification Code Term Level
    12.0 10021036 Hyponatraemia LLT
    12.0 10017955 Gastrointestinal haemorrhage LLT
    12.0 10040108 Serotonin syndrome LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-003339-39 Sponsor Protocol Number: EHDA-01 Start Date*: 2017-05-03
    Sponsor Name:JOSÉ MARÍA PALAZÓN AZORÍN
    Full Title: A randomized, controlled and double-blind trial of intravenous azithromycin versus intravenous erythromycin as a single dose prior to endoscopy in upper gastrointestinal bleeding
    Medical condition: Upper gastrointestinal haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    19.1 10017947 - Gastrointestinal disorders 10046274 Upper gastrointestinal haemorrhage PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-004588-29 Sponsor Protocol Number: TA799-101 Start Date*: 2022-02-01
    Sponsor Name:VectivBio AG
    Full Title: A randomized, single-blind trial to evaluate the safety and efficacy of apraglutide in subjects with Grade II to IV (MAGIC) steroid refractory gastrointestinal (GI) acute graft versus host disease ...
    Medical condition: Acute graft versus host disease (aGVHD)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021428 - Immune system disorders 10075160 Graft versus host disease in gastrointestinal tract PT
    20.0 10021428 - Immune system disorders 10075161 Graft versus host disease in GI tract LLT
    20.1 10021428 - Immune system disorders 10066264 Acute graft versus host disease in intestine PT
    20.1 10021428 - Immune system disorders 10066260 Acute graft versus host disease PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Trial now transitioned) ES (Ongoing) PT (Prematurely Ended) FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006409-18 Sponsor Protocol Number: 9463-EC-0002 Start Date*: 2010-02-09
    Sponsor Name:Astellas Pharma Europe Ltd.
    Full Title: An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis versus Placebo in High Risk Surgical Subjects - A Multicentre, Randomized, D...
    Medical condition: Invasive Candidiasis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10007152 Candidiasis LLT
    12.1 10007162 Candidiasis of the intestine LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) ES (Completed) HU (Completed) BE (Completed) GR (Completed) DE (Completed) FR (Completed) FI (Completed) IT (Completed) GB (Completed) DK (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2011-005169-20 Sponsor Protocol Number: Peripheral9000 Start Date*: 2012-02-14
    Sponsor Name:Mech-Sense, Department og Gastroenterology, Aalborg Sygehus
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004856 10018000 Gastrointestinal pain NOS LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-002697-39 Sponsor Protocol Number: MPOH03 Start Date*: 2019-01-11
    Sponsor Name:MaaT Pharma
    Full Title: Treatment of steroid refractory gastro-intestinal acute graft-versus-Host disEase afteR AllogeneiC hematopoietic stem celL transplantation with fEcal microbiota transfer (HERACLES)
    Medical condition: Steroid refractory gastro-intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed) PL (Prematurely Ended) GB (GB - no longer in EU/EEA) IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2021-003085-12 Sponsor Protocol Number: ANT-008 Start Date*: 2022-05-10
    Sponsor Name:Anthos Therapeutics
    Full Title: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding i...
    Medical condition: venous thromboembolism (VTE) in patients with gastrointestinal/genitourinary cancer
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Trial now transitioned) NO (Trial now transitioned) FR (Trial now transitioned) IE (Trial now transitioned) ES (Ongoing) HU (Trial now transitioned) IT (Trial now transitioned) NL (Trial now transitioned) SE (Trial now transitioned) AT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2004-001234-17 Sponsor Protocol Number: A3191084 Start Date*: 2006-06-15
    Sponsor Name:Pfizer Limited
    Full Title: Double-blind, triple dummy, parallel-group, randomized, six-month study to compare celecoxib (200 mg BID) with diclofenac SR (75 mg BID) plus omeprazole (20 mg QD) for gastrointestinal events in su...
    Medical condition: Treatment of osteoarthritis (OA) and/or rheumatoid arthritis (RA) in high GI risk patients
    Disease: Version SOC Term Classification Code Term Level
    8.0 10039073 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) ES (Completed) BE (Completed) SE (Completed) CZ (Completed) LT (Completed) DE (Suspended by CA) EE (Completed) PT (Completed) GR (Completed) IE (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2021-001841-11 Sponsor Protocol Number: MPOH06 Start Date*: 2021-11-09
    Sponsor Name:MaaT Pharma
    Full Title: Evaluation of the efficacy of MaaT013 as salvage therapy in acute GVHD patients with gastrointestinal involvement, refractory to ruxolitinib; a multi-center open-label phase III trial
    Medical condition: Salvage therapy of acute GVHD patients with gastrointestinal involvement, refractory to ruxolitinib.
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021428 - Immune system disorders 10066264 Acute graft versus host disease in intestine PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned) ES (Ongoing) AT (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 23:45:01 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA